Coverage dated November 22, 2022
FDA approves $3.5 million treatment for hemophilia, now the most expensive drug in the world Headline from CBS News
FDA approved Hemgenix based on safety and effectiveness evaluated in two studies of about 60 adult men.
CBS News's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
Reports & sources Newest first Show outlet leaning
Filter reports by outlet or headline words
16 articles, oldest first.
CBS News
FDA approves $3.5 million treatment for hemophilia, now the most expensive drug in the world ↗ (opens CBS News) Published Nov 22, 2022
CBS News's feed description FDA approved Hemgenix based on safety and effectiveness evaluated in two studies of about 60 adult men.
The Guardian
Gene therapy at $3.5m a dose approved for US adults with hemophilia B ↗ (opens The Guardian) Published Nov 22, 2022
The Guardian's feed description Hemgenix frees patients from repeated treatments but initial cost makes it most expensive medicine in the world
WFMZ Allentown
$3.5M gene therapy for hemophilia gets FDA approval ↗ (opens WFMZ Allentown) Published Nov 22, 2022
Same headline from 8 more outlets WFMZ Allentown's feed description U.S. health regulators have approved the first gene therapy for hemophilia, a blood-clotting disorder with few treatment options. The maker of the one-time treatment said the drug will cost $3.5
CBS News
FDA approves most expensive drug ever, a $3.5 million-per-dose gene therapy for hemophilia B ↗ (opens CBS News) Published Nov 22, 2022
CBS News's feed description The single-dose medicine "represents important progress" as the first-ever gene therapy for the rare disorder, the FDA said.
St. Louis Post-Dispatch
A Gene Therapy for Hemophilia That Costs $3.5 Million Gets FDA Approval ↗ (opens St. Louis Post-Dispatch) Published Nov 22, 2022
Same headline from 2 more outlets St. Louis Post-Dispatch's feed description WEDNESDAY, Nov. 23, 2022 (HealthDay News) -- People with one form of the genetic blood disorder hemophilia now have a one-time treatment with a $3.5 million price tag.
ABC 12 Flint
FDA approves $3.5 million treatment for hemophilia ↗ (opens ABC 12 Flint) Published Nov 22, 2022
ABC 12 Flint's feed description The U.S. Food and Drug Administration on Tuesday approved Hemgenix, a new drug to treat hemophilia.
Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.
